CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097988 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Valentina Muto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Fondazione Bambino Gesù, Ricerca Corrente.
Abstract (Originalsprache)
Induced pluripotent stem cells (iPSCs) have been established as a reliable in vitro disease model system and represent a particularly informative tool when animal models are not available or do not recapitulate the human pathophenotype. The recognized limit in using this technology is linked to some degree of variability in the behavior of the individual patient-derived clones. The development of CRISPR/Cas9-based gene editing solves this drawback by obtaining isogenic iPSCs in which the genetic lesion is corrected, allowing a straightforward comparison with the parental patient-derived iPSC lines. Here, we report the generation of a footprint-free isogenic cell line of patient-derived TBCD-mutated iPSCs edited using the CRISPR/Cas9 and piggyBac technologies. The corrected iPSC line had no genetic footprint after the removal of the selection cassette and maintained its “stemness”. The correction of the disease-causing TBCD missense substitution restored proper protein levels of the chaperone and mitotic spindle organization, as well as reduced cellular death, which were used as read-outs of the TBCD KO-related endophenotype. The generated line represents an informative in vitro model to understand the impact of pathogenic TBCD mutations on nervous system development and physiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
- Department of Science, University Roma Tre, 00146 Rome, Italy.
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.
- Neuroendocrinology Metabolism and Neuropharmacology Unit, IRCSS Fondazione Santa Lucia, 00143 Rome, Italy.
- Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, 00185 Rome, Italy.
- Center for Life Nano- & Neuro-Science, Fondazione Istituto Italiano di Tecnologia (IIT), 00161 Rome, Italy.
ORCID-Profile: Valentina Magliocca, Valentina Pallottini, Alessandro Rosa, Claudia Compagnucci, Marco Tartaglia
Förderung
- Italian Ministry of Health
- Fondazione Bambino Gesù
- Ricerca Corrente
- Ricerca Finalizzata Giovani Ricercatori
Zitieren
APA
Muto, V., Benigni, F., Magliocca, V., Borghi, R., Flex, E., Pallottini, V., Rosa, A., Compagnucci, C., & Tartaglia, M. (2023). CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097988
Vancouver
Muto V, Benigni F, Magliocca V, Borghi R, Flex E, Pallottini V, et al. CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097988
BibTeX
@article{Muto2023,
author = {Muto, Valentina and Benigni, Federica and Magliocca, Valentina and Borghi, Rossella and Flex, Elisabetta and Pallottini, Valentina and Rosa, Alessandro and Compagnucci, Claudia and Tartaglia, Marco},
title = {CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097988}
}
EUVIMED